A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2023-02-01
|
| Sarja: | Journal of Microbiology, Immunology and Infection |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S1684118222002869 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|